Recent Trends in Infectious Diseases

Recent Trends in Infectious Diseases [3048-9857(e)] is a peer-reviewed open-access journal launched in 2024 that are a significant global health challenge, with outbreaks and epidemics occurring frequently, and new diseases emerging. Recent trends in infectious diseases have highlighted the importance of understanding the transmission, diagnosis, and treatment of these diseases. This paper aims to provide an overview of the current state of infectious diseases, recent trends, and future directions. The recent trends in infectious diseases focus on, emerging and re-emerging infections, zoonotic diseases, the impact of climate change, and the increasing problem of antimicrobial resistance. The paper will cover both human and animal infectious diseases, with a focus on the mechanisms of transmission, prevention, and treatment.

• • Emerging and Re-emerging Infectious Diseases: Outbreaks, epidemics, and pandemics, novel viruses, influenza and avian influenza, coronaviruses including SARS and MERS, Ebola and Marburg viruses, Nipah and Hendra viruses, Zika, chikungunya, dengue, cholera, reservoirs and spillover hosts.
  • Zoonotic Diseases and One Health: Animal-to-human transmission, reservoir hosts, wildlife and livestock disease, rabies, brucellosis, leptospirosis, Q fever, tularemia, plague, Lassa fever, salmonellosis, collaboration across human, animal, and environmental health.
  • Climate Change and Vector-Borne Infections: Mosquito- and tick-borne disease, malaria, yellow fever, West Nile virus, Lyme disease, Rocky Mountain spotted fever, rodent-borne infection, waterborne and diarrheal disease, cryptosporidiosis, melioidosis, heat waves and extreme weather, climate adaptation.
  • Antimicrobial Resistance: Multidrug resistance in bacteria, viruses, fungi, and parasites, resistance genes, MRSA, vancomycin-resistant enterococci, carbapenem-resistant Enterobacterales, extended-spectrum beta-lactamase producers, drug-resistant tuberculosis, Clostridioides difficile, resistant gonorrhea, antibiotic overuse, stewardship programs, hospital- and community-acquired infection.
  • Bacterial, Viral, Fungal, and Parasitic Infections: Pathogen biology, transmission dynamics, host–pathogen interactions, virulence and persistence, the microbiome in infection, pneumococcal disease, invasive fungal infection, parasitic disease.
  • Diagnosis and Treatment: Culture, serology, molecular and point-of-care diagnostics, antimicrobial susceptibility testing, differential diagnosis, antibacterial, antiviral, and antifungal therapy, combination therapy, therapeutic drug monitoring, adverse drug reactions, drug interactions, clinical trials, treatment outcomes.
  • Prevention, Vaccines, and Infection Control: Vaccine development, immunization programs, vaccine-preventable disease, prophylaxis, hospital infection prevention and control, hygiene and sanitation, isolation and quarantine, equitable access to prevention.
  • Surveillance, Genomics, and Global Health Security: Disease surveillance systems, outbreak investigation and rapid response, pathogen genomics and molecular typing, transmission modeling, digital tools and artificial intelligence for outbreak detection, travel medicine, preparedness and public health policy.

  The journal publishes original research articles, reviews, case reports, and short communications. Non-infectious clinical studies, such as oncology and general surgery, are out of scope unless they address infection. The journal serves infectious disease clinicians, microbiologists, epidemiologists, veterinarians, public health professionals, and policymakers.